A symposium named after Edwin G. Krebs, the one Nobel laureate up to now from UC Davis, will characteristic a keynote handle from UC Berkeley Nobel Laureate Jennifer Doudna.
The Krebs Symposium, hosted by the Division of Biochemistry and Molecular Medication, is being held Might 15 from midday to five p.m. on the UC Davis Convention Heart in Davis.
Doudna, a biochemist, is a Howard Hughes Medical Institute Investigator at UC Berkeley and founding father of the Revolutionary Genomics Institute. She can be the Li Ka Shing Chancellor’s Professor of Biomedical Science.
Doudna gained the 2020 Nobel Prize in Chemistry, sharing it with colleague Emmanuelle Charpentier, for the co-development of CRISPR-Cas9. The genome modifying breakthrough has revolutionized biomedicine, enabling scientists to vary or take away genes shortly and with nice precision.
The namesake of the symposium, Edwin G. Krebs, was the founding chair of the Division of Biochemistry and Molecular Medication. Krebs shared the Nobel Prize in Physiology or Medication in 1992 with Edmond H. Fischer for “their discoveries regarding reversible protein phosphorylation as a organic regulatory mechanism.”
Attendance on the Krebs Symposium is restricted to 250 individuals. Lunch will likely be offered originally of the occasion. School, postdoctoral students, workers and college students are invited to enroll with their UC Davis e mail handle right here. The deadline for registration is Monday, Might 1.
12:00 p.m. — Lunch
1:00 p.m. — Opening remarks from UC Davis Chancellor Gary Might and Vice Dean for Analysis Kim Barrett
1:15 p.m. — Shows from the Division of Biochemistry and Molecular Medication
2:30 p.m. — Keynote handle from Jennifer Doudna, professor, UC Berkeley
4:00 p.m. — Poster session for college kids and post-doctoral students
For questions in regards to the occasion, contact Adriane Joo, chief administrative officer for the Division of Biochemistry and Molecular Medication, at firstname.lastname@example.org.